title: [The use of Cardioxan as a cardioprotective agent during antitumor chemotherapy].
authors.forename: M R
authors.initials: MR
authors.lastname: Lichinitser
authors.forename: G V
authors.initials: GV
authors.lastname: Vyshinskaia
authors.forename: E D
authors.initials: ED
authors.lastname: Min'kov
authors.forename: T A
authors.initials: TA
authors.lastname: Nakhalova
authors.forename: A A
authors.initials: AA
authors.lastname: Odzharova
authors.forename: A M
authors.initials: AM
authors.lastname: Garin
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy; D009202:Cardiomyopathies / Q000139:chemically induced / Q000517:prevention & control; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D004347:Drug Interactions; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D011929:Razoxane / Q000627:therapeutic use*; D012074:Remission Induction
chemical_list: D002317:Cardiovascular Agents; D011929:Razoxane; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil
vernacular_title: Primenenie kardioksana v kachestve kardioprotektornogo sredstva pri protivoopukholevoĭ khimioterapii.